About: generic medicine
Pharma industry raises the alarm about stockpiling of generic drugs
The industry of innovative medicines is concerned with a recent vote in the European Parliament on the stockpiling of generic drugs, saying that it causes uncertainty over innovation in the pharmaceutical field.
Discussion heats up over stockpiling of generic drugs under patent protection
The Commission has announced its intention to add a manufacturing waiver to supplementary protection certificates (SPC), as part of its upgraded 2015 Single Market Strategy.
Andriukaitis: SPC manufacturing waiver does not damage pharma innovation
The European Commission’s proposal to add an SPC manufacturing waiver on exports will not damage innovation, as the pharma industry claims, and only intends to support small and medium generic drug companies, according to EU Health Commissioner Vytenis Andriukaitis.
Novartis under scrutiny for alleged pharma scandal in Greece
The Greek government launched an official investigation into pharmaceutical giant Novartis, following the publication of allegations of corruption and bribery in national news media.
Pharma industry ‘cannot escape’ drug price talks, say patient groups
Patient groups and the pharmaceutical sector agree that access to medicines needs to be improved - but the way to do it seems to divide them. EURACTIV.com reports from Sofia.
EU health ministers confront crisis in affordability of medicines
EU health ministers took reluctant steps last Friday (17 June) to address the rising price of medicines.
Germans spend more on medicine than most of Europe
Expenditure on medicinal drugs in Germany is higher than in most other European countries, according to the OECD. EURACTIV Germany reports.